Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy

European urology oncology - Tập 4 - Trang 868-876 - 2021
Valeria Panebianco1, Geert Villeirs2, Jeffrey C. Weinreb3, Baris I. Turkbey4, Daniel J. Margolis5, Jonathan Richenberg6, Ivo G. Schoots7,8, Caroline M. Moore9, Jurgen Futterer10, Katarzyna J. Macura11, Aytekin Oto12, Leonardo K. Bittencourt13, Masoom A. Haider14, Georg Salomon15, Clare M. Tempany16, Anwar R. Padhani17, Jelle O. Barentsz10
1Department of Radiological Sciences, Oncology and Pathology, Sapienza University/Policlinico Umberto I, Rome, Italy
2Department of Radiology and Nuclear Medicine, Ghent University Hospital, Ghent, Belgium
3Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA
4National Cancer Institute, Center for Cancer Research, Bethesda, MD, USA
5Weill Cornell Imaging, Cornell University, New York, NY, USA
6Department of Imaging, Brighton and Sussex University Hospitals NHS Trust and Brighton and Sussex Medical School, Brighton, UK
7Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
8Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
9Department of Urology, University College London, London, UK
10Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, the Netherlands
11Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA
12Department of Radiology, University of Chicago, Chicago, IL, USA
13Department of Radiology, University Hospitals Cleveland Medical Center, Cleveland, Ohio
14Department of Medical Imaging, University of Toronto, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Canada
15Martini-Clinic Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany
16Department of Radiology, Brigham & Women’s Hospital, Boston, MA, USA
17Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, UK

Tài liệu tham khảo

Mottet Lowrance, 2021, Advanced prostate cancer: AUA/ASTRO/SUO guideline part I, J Urol, 205, 14, 10.1097/JU.0000000000001375 Rouvière, 2010, Imaging of prostate cancer local recurrences: why and how?, Eur Radiol, 20, 1254, 10.1007/s00330-009-1647-4 De Visschere, 2019, A systematic review on the role of imaging in early recurrent prostate cancer, Eur Urol Oncol, 2, 47, 10.1016/j.euo.2018.09.010 Lopes Dias, 2015, Post-treated prostate cancer: normal findings and signs of local relapse on multiparametric magnetic resonance imaging, Abdom Imaging, 40, 2814, 10.1007/s00261-015-0473-1 Sella, 2004, Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging, Radiology, 231, 379, 10.1148/radiol.2312030011 Mertan, 2016, Multiparametric magnetic resonance imaging of recurrent prostate cancer, Top Magn Reson Imaging, 25, 139, 10.1097/RMR.0000000000000088 Allen, 2008, The normal post-surgical anatomy of the male pelvis following radical prostatectomy as assessed by magnetic resonance imaging, Eur Radiol, 18, 1281, 10.1007/s00330-008-0867-3 Coakley, 2004, Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience, Radiology, 233, 441, 10.1148/radiol.2332032086 Vargas, 2012, MR imaging of treated prostate cancer, Radiology, 262, 26, 10.1148/radiol.11101996 Gaur, 2018, Prostate MR imaging for posttreatment evaluation and recurrence, Urol Clin North Am, 45, 467, 10.1016/j.ucl.2018.03.011 Patel, 2018, Multiparametric MR imaging of the prostate after treatment of prostate cancer, RadioGraphics, 38, 437, 10.1148/rg.2018170147 Turkbey, 2019, Prostate Imaging Reporting and Data System version 2.1: 2019 update of Prostate Imaging Reporting and Data System version 2, Eur Urol, 76, 340, 10.1016/j.eururo.2019.02.033 Patel, 2016, Magnetic resonance imaging of the prostate, including pre- and postinterventions, Semin Interv Radiol, 33, 186, 10.1055/s-0036-1586144 Arrayeh, 2012, Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study, Int J Radiat Oncol Biol Phys, 82, e787, 10.1016/j.ijrobp.2011.11.030 Jalloh, 2015, Patterns of local failure following radiation therapy for prostate cancer, J Urol, 194, 977, 10.1016/j.juro.2015.04.111 Sugimura, 1990, Postirradiation changes in the pelvis: assessment with MR imaging, Radiology, 175, 805, 10.1148/radiology.175.3.2343132 Chan, 1991, Prostate and seminal vesicles after irradiation: MR appearance, J Magn Reson Imaging, 1, 503, 10.1002/jmri.1880010502 Maurer, 2016, Imaging for prostate cancer recurrence, Eur Urol Focus, 2, 139, 10.1016/j.euf.2016.02.006 McCammack, 2016, Imaging of local recurrence in prostate cancer, Fut Oncol, 12, 2401, 10.2217/fon-2016-0122 Pucar, 2005, Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy—initial experience, Radiology, 236, 545, 10.1148/radiol.2362040739 Maenhout, 2017, Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer, J Contemp Brachyther, 2, 161, 10.5114/jcb.2017.67015 Westphalen, 2009, T2-weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy, Int Braz J Urol, 35, 171, 10.1590/S1677-55382009000200007 Foltz, 2013, Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer, J Magn Reson Imaging, 37, 909, 10.1002/jmri.23885 Song, 2010, Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T, Am J Roentgenol, 194, W477, 10.2214/AJR.09.3557 Rouvière, 2004, Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor—correlation with biopsy findings, Urology, 63, 922, 10.1016/j.urology.2003.12.017 Franiel, 2009, Radiother Oncol, 93, 241, 10.1016/j.radonc.2009.08.016 Schiavina, 2013, The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques?, Curr Radiopharm, 6, 92, 10.2174/1874471011306020005 Haider, 2008, Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy, Int J Radiat Oncol Biol Phys, 70, 425, 10.1016/j.ijrobp.2007.06.029 Roy, 2013, Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy, Am J Roentgenol, 200, W361, 10.2214/AJR.12.9106 Alonzo, 2016, Detection of locally radio-recurrent prostate cancer at multiparametric MRI: can dynamic contrast-enhanced imaging be omitted?, Diagn Interv Imaging, 97, 433, 10.1016/j.diii.2016.01.008 Rud, 2014, Detection of radiorecurrent prostate cancer using diffusion-weighted imaging and targeted biopsies, Am J Roentgenol, 202, W241, 10.2214/AJR.12.10483 Tamada, 2011, Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors, Am J Roentgenol, 197, 408, 10.2214/AJR.10.5772 Donati, 2013, Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy?, Radiology, 268, 440, 10.1148/radiol.13122149 Valle, 2018, Multiparametric MRI for the detection of local recurrence of prostate cancer in the setting of biochemical recurrence after low dose rate brachytherapy, Diagn Interv Radiol, 24, 46, 10.5152/dir.2018.17285 Abd-Alazeez, 2015, Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images, Prostate Cancer Prostat Dis, 18, 128, 10.1038/pcan.2014.55 Akin, 2011, Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results, Eur Radiol, 21, 1970, 10.1007/s00330-011-2130-6 Barchetti, 2014, Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy, BioMed Res Int, 2014, 1 Cirillo, 2009, Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging, Eur Radiol, 19, 761, 10.1007/s00330-008-1174-8 Sandgren, 2019, Imaging for the detection of locoregional recurrences in biochemical progression after radical prostatectomy—a systematic review, Eur Urol Focus, 5, 550, 10.1016/j.euf.2017.11.001 Kwon, 2018, Discrimination of local recurrence after radical prostatectomy: value of diffusion-weighted magnetic resonance imaging, Prostate Int, 6, 12, 10.1016/j.prnil.2017.05.002 Casciani, 2008, Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy, Am J Roentgenol, 190, 1187, 10.2214/AJR.07.3032 Panebianco, 2013, Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging, Eur Radiol, 23, 1745, 10.1007/s00330-013-2768-3 Kitajima, 2015, Detection of local recurrence of prostate cancer after radical prostatectomy using endorectal coil MRI at 3 T: addition of DWI and dynamic contrast enhancement to T2-weighted MRI, Am J Roentgenol, 205, 807, 10.2214/AJR.14.14275 Litwin, 2017, The diagnosis and treatment of prostate cancer: a review, JAMA, 317, 2532, 10.1001/jama.2017.7248 Bekelman, 2018, Clinically localized prostate cancer: ASCO Clinical Practice Guideline endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline, J Clin Oncol, 36, 3251, 10.1200/JCO.18.00606 Van den Broeck, 2020, Biochemical recurrence in prostate cancer: the European Association of Urology Prostate Cancer Guidelines Panel recommendations, Eur Urol Focus, 6, 231, 10.1016/j.euf.2019.06.004 Lindenberg, 2020, Evaluating biochemically recurrent prostate cancer: histologic validation of 18 F-DCFPyL PET/CT with comparison to multiparametric MRI, Radiology, 296, 564, 10.1148/radiol.2020192018 Afshar-Oromieh, 2019, Comparison of PSMA-ligand PET/CT and multiparametric MRI for the detection of recurrent prostate cancer in the pelvis, Eur J Nucl Med Mol Imaging, 46, 2289, 10.1007/s00259-019-04438-w Calais, 2019, 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial, Lancet Oncol, 20, 1286, 10.1016/S1470-2045(19)30415-2
Thông tin
Thông tin xuất bản

European urology oncology

Tập 4

868-876

Thông tin tác giả